Your browser doesn't support javascript.
loading
Characterization of intrinsic and effective fitness changes caused by temporarily fixed mutations in the SARS-CoV-2 spike E484 epitope and identification of an epistatic precondition for the evolution of E484A in variant Omicron.
Schröder, Simon; Richter, Anja; Veith, Talitha; Emanuel, Jackson; Gudermann, Luca; Friedmann, Kirstin; Jeworowski, Lara M; Mühlemann, Barbara; Jones, Terry C; Müller, Marcel A; Corman, Victor M; Drosten, Christian.
Afiliación
  • Schröder S; Institute of Virology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Richter A; Institute of Virology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Veith T; Institute of Virology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Emanuel J; Institute of Virology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Gudermann L; Institute of Virology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Friedmann K; Institute of Virology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Jeworowski LM; Institute of Virology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Mühlemann B; Institute of Virology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Jones TC; Institute of Virology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Müller MA; Centre for Pathogen Evolution, Department of Zoology, University of Cambridge, Downing St, CB2 3EJ, Cambridge, U.K.
  • Corman VM; Institute of Virology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Drosten C; Institute of Virology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Virol J ; 20(1): 257, 2023 11 08.
Article en En | MEDLINE | ID: mdl-37940989
BACKGROUND: Intrinsic fitness costs are likely to have guided the selection of lineage-determining mutations during emergence of variants of SARS-CoV-2. Whereas changes in receptor affinity and antibody neutralization have been thoroughly mapped for individual mutations in spike, their influence on intrinsic replicative fitness remains understudied. METHODS: We analyzed mutations in immunodominant spike epitope E484 that became temporarily fixed over the pandemic. We engineered the resulting immune escape mutations E484K, -A, and -Q in recombinant SARS-CoV-2. We characterized viral replication, entry, and competitive fitness with and without immune serum from humans with defined exposure/vaccination history and hamsters monospecifically infected with the E484K variant. We additionally engineered a virus containing the Omicron signature mutations N501Y and Q498R that were predicted to epistatically enhance receptor binding. RESULTS: Multistep growth kinetics in Vero-, Calu-3, and NCI-H1299 were identical between viruses. Synchronized entry experiments based on cold absorption and temperature shift identified only an insignificant trend toward faster entry of the E484K variant. Competitive passage experiments revealed clear replicative fitness differences. In absence of immune serum, E484A and E484Q, but not E484K, were replaced by wildtype (WT) in competition assays. In presence of immune serum, all three mutants outcompeted WT. Decreased E484A fitness levels were over-compensated for by N501Y and Q498R, identifying a putative Omicron founder background that exceeds the intrinsic and effective fitness of WT and matches that of E484K. Critically, the E484A/Q498R/N501Y mutant and E484K have equal fitness also in presence of pre-Omicron vaccinee serum, whereas the fitness gain by E484K is lost in the presence of serum raised against the E484K variant in hamsters. CONCLUSIONS: The emergence of E484A and E484Q prior to widespread population immunity may have been limited by fitness costs. In populations already exposed to the early immune escape epitope E484K, the Omicron founder background may have provided a basis for alternative immune escape evolution via E484A. Studies of major antigenic epitope changes with and without their epistatic context help reconstruct the sequential adjustments of intrinsic fitness versus neutralization escape during the evolution of major SARS-CoV-2 variants in an increasingly immune human population.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Animals / Humans Idioma: En Revista: Virol J Asunto de la revista: VIROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Límite: Animals / Humans Idioma: En Revista: Virol J Asunto de la revista: VIROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Alemania